At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...

A team of bioengineers at Harvard University's Rowland Institute has found two new ways to control a tiny creature, ...

Trump’s tariffs aim to bring manufacturing back to the U.S. So what—besides magic—would it take to make iPhones here?

A Texas-based startup has revived the long-extinct dire wolf, but should we take their efforts with a pinch of salt?

Colossal Biosciences revealed its small pack of genetically modified dire wolves. The company's "de-extinction" plans include ...

Supreme Court allows mass deportations, Florida wins the NCAA title, and more in today’s edition of The Yodel newsletter ...

The fallout comes amid a yearslong slog for biotech, which has struggled since high interest rates and inflation curbed what ...

K Health's AI model is not designed to replace doctors, but rather to help them provide better care. But can it hold a ...

Americans elected Donald Trump with a favorable opinion of his economic plans. But his tariff plan has helped turn that ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

UC ANR Innovate, the innovation arm of University of California Agriculture and Natural Resources, has received a significant ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...